Pulmonary Arterial Hypertension
Pt with h/o congenital heart disease/failure, OSA, COPD, PE, DVT, systemic sclerosis, HIV, and schistosomiasis presents with dyspnea on exertion and fatigue. Reports recent angina, syncope. SPO2 < 90%, JVD, LE edema on exam.
Obtain CBC, BMP, BNP, TSH
EKG shows R ventricular enlargement, right bundle branch block, and S1Q3T3 pattern suggestive of PE
Echocardiogram indicates pulmonary arterial pressure > 25 mmHg
Refer for pulmonary function testing, sleep apnea testing
Pulmonary arterial pressure > 35 mmHg: Refer to cardiology for possible R heart catheterization
Treatment
Vaccination
Administer influenza vaccine, PPSV23
> 65 y/o: Administer PCV13 followed by PPSV23 in 6 months to 1 year
No h/o COPD: Start nifedipine ER 60 mg daily
Resting SPO2 < 88% and/or PaO2 < 60 mmHg: Start oxygen therapy
Etiology-specific
Optimize HFpEF and obstructive lung disease regimens
Chronic pulmonary thromboembolic disease: Consider lifelong anticoagulation and/or pulmonary endarterectomy
Referral
Condition complicated by heart failure: Refer to cardiology
Refer to pulmonology based on right heart catheterization results
Pt counseled that guidelines advise against pregnancy and recommend long-active reversible contraception
Notes
Normal pulmonary artery pressure = 25 mmHg
Potential etiologies
Group 1
Includes congenital conditions, connective tissue disease, iatrogenic
Specific risk factors: HIV, systemic sclerosis, congenital heart disease, and schistosomiasis
Group 2: Chronic heart failure (left heart disease)
Group 3: Obstructive or interstitial lung disease
Vasodilators (e.g. nifedipine, sildenafil, bosentan) create ventilation-perfusion mismatch and can worsen symptoms
Start supplemental oxygen when PaO2 < 60 mmHg
Group 4: Chronic pulmonary thromboemboli (endarterectomy may be indicated)
Group 5: Multifactorial, e.g. sickle cell disease
Most common cause of death is right heart failure